Wells Fargo Upgrades NuVasive (NUVA) to Outperform; Spine Market has Bottomed
Tweet
Share
E-mailGet Alerts NUVA Hot Sheet
Price: $39.75 --0%
Rating Summary:
11 Buy, 21 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Rating Summary:
11 Buy, 21 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 18 | New: 20
Join SI Premium – FREE
Wells Fargo upgraded NuVasive (NASDAQ: NUVA) from Market Perform to Outperform, price target range raised from $17-18 to $29-31.
Analyst, Larry Biegelsen, said, "...we believe (1) the spine market has bottomed out; (2) NUVA's 2012 guidance and consensus appear overly conservative; (3) the possible elimination of the medical device tax represents significant upside potential to NUVA; and (4) valuation remains attractive.
For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.
Shares of NuVasive closed at $22.92 yesterday.
Analyst, Larry Biegelsen, said, "...we believe (1) the spine market has bottomed out; (2) NUVA's 2012 guidance and consensus appear overly conservative; (3) the possible elimination of the medical device tax represents significant upside potential to NUVA; and (4) valuation remains attractive.
For an analyst ratings summary and ratings history on NuVasive click here. For more ratings news on NuVasive click here.
Shares of NuVasive closed at $22.92 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Johnson Rice Upgrades Big Sky Industrials (BSIN) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
